var title_f9_19_9520="Circinate exudate";
var content_f9_19_9520=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F79466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F79466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Circinate exudate: Appearance on fundus photograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color fundus photograph of extensive yellow circinate exudate in the macula; intraretinal hemorrhages and previous peripheral laser treatment are also visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9520=[""].join("\n");
var outline_f9_19_9520=null;
var title_f9_19_9521="Fordyce spots - buccal";
var content_f9_19_9521=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69406&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fordyce spots",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small yellow papules are present on the buccal mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9521=[""].join("\n");
var outline_f9_19_9521=null;
var title_f9_19_9522="FAST perisplenic normal";
var content_f9_19_9522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    FAST: Perisplenic (left flank) view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 404px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This image, obtained as part of the FAST examination, shows normal juxtaposition of the spleen (S) and left kidney (K) without free fluid.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Greg Snead, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9522=[""].join("\n");
var outline_f9_19_9522=null;
var title_f9_19_9523="Colpotomy";
var content_f9_19_9523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Colpotomy during laparoscopic hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Lyons, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9523=[""].join("\n");
var outline_f9_19_9523=null;
var title_f9_19_9524="Adenovirus (types 4, 7) vaccine: Drug information";
var content_f9_19_9524=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Adenovirus (types 4, 7) vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/58/20387?source=see_link\">",
"    see \"Adenovirus (types 4, 7) vaccine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F12641206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Live (Viral)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F12641218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Adenovirus immunization:",
"     </b>",
"     Oral: Adults &le;50 years: One tablet each of type 4 and type 7 taken together as a single vaccine dose",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F12641217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adolescents &ge;17 years: Refer to Adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15671326\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15671327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13172357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet, enteric coated, oral [combination package]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adenovirus type 4 &ge;4.5 log",
"     <sub>",
"      10",
"     </sub>",
"     TCID",
"     <sub>",
"      50",
"     </sub>",
"     [contains albumin (human); 100 white tablets]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adenovirus type 7 &ge;4.5 log",
"     <sub>",
"      10",
"     </sub>",
"     TCID",
"     <sub>",
"      50",
"     </sub>",
"     [contains albumin (human); 100 white tablets]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F12641192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F12641189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product is approved for use in military populations",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12641219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Swallow tablets whole, do not chew, crush, or split. Both tablets (type 4 and type 7) are to be taken together as a single dose.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F12641193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention of acute febrile respiratory disease caused by adenovirus types 4 and 7 (approved for use in military populations)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12641201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Central nervous system: Headache (7% to 30%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Gastrointestinal: Nausea (5% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Respiratory: Nasal congestion (8% to 15%), pharyngolaryngeal pain (12% to 13%), cough (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Central nervous system: Fever (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Gastrointestinal: Diarrhea (3% to 10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Neuromuscular &amp; skeletal: Limb pain (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     Respiratory: Rhinorrhea (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     &lt;1% (Limited to important or life-threatening): Gastritis, gastroenteritis, hematuria, hematochezia, pneumonia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12641197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Severe hypersensitivity  to adenovirus (types 4 and 7) vaccine or any component of the formulation; pregnancy; inability to swallow the table whole",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12641198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Gastrointestinal illness: Vomiting or diarrhea may decrease the effectiveness of the vaccine (may reduce adenovirus replication within the gastrointestinal tract); administration should be postponed in patients with vomiting or diarrhea.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Immunocompromised patients: The safety and effectiveness of use in immunocompromised patients has not been evaluated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Albumin: Formulation contains albumin, which may carry a remote risk of viral transmission, including a theoretical risk of Creutzfeldt-Jakob disease transmission.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate administration: Tablets should be swallowed whole; do not chew. Chewing could potentially release the virus into the respiratory tract leading to disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Viral shedding: Contains live viruses that are shed in the stool and may be transmitted. If exposed, close contacts (including those recently vaccinated) may develop adenovirus infection. Vaccinated individuals should use caution if in close contact with children &lt;7 years of age, immunocompromised patients, or pregnant women for 28 days following administration.  Wash hands frequently, especially following bowel movements, for 28 days after administration.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F12757372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AzaTHIOprine: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Fingolimod may diminish the therapeutic effect of Vaccines (Live).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hydroxychloroquine: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immune Globulins: May diminish the therapeutic effect of Vaccines (Live). Management: Live organism vaccination should be withheld for up to 6 months following immune globulin administration.  Live vaccine given immediately prior to immune globulin may require repeat vaccination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live). Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     AzaTHIOprine; Beclomethasone (Oral Inhalation); Betamethasone; Budesonide (Systemic, Oral Inhalation); Corticotropin; Cortisone; Cytarabine (Liposomal); Dexamethasone (Systemic); Fludrocortisone; Fluticasone (Oral Inhalation); Hydrocortisone (Systemic); Hydroxychloroquine; Leflunomide; Mercaptopurine; Methotrexate; MethylPREDNISolone; PrednisoLONE (Systemic); PredniSONE; Triamcinolone (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mercaptopurine: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: May enhance the adverse/toxic effect of Vaccines (Live).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tuberculin Tests: Vaccines (Live) may diminish the diagnostic effect of Tuberculin Tests.  Management: If a parenteral live vaccine has been recently administered, a scheduled PPD skin test should not be administered for at least 4-6 weeks following the administration of the vaccine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12641194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use in pregnancy is contraindicated. Naturally-occurring adenovirus infections are associated with fetal harm. Information following inadvertent use during pregnancy is limited. Women of childbearing potential should avoid becoming pregnant for 6 weeks following vaccination. Healthcare providers are encouraged to enroll women exposed to adenovirus vaccine during  pregnancy (or pregnancies occurring within 6 weeks of vaccination) in the Adenovirus Pregnancy Registry at 1-866-790-4549. Pregnant women should use caution if in close contact with vaccinated individuals for 28 days following vaccine administration.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12641195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12641196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if adenovirus (types 4 and 7) vaccine is excreted in breast milk. However, viral shedding may occur and individuals should use caution when in close contact with children &lt;7 years of age. Because many viruses are excreted in human breast milk, caution should be used if administered to a lactating woman.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12641209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Nonattenuated preparation of live adenovirus types 4 and 7 designed to release the live viruses in the intestine and replicate (in the intestinal tract) to induce immunity in individuals without (or with low) existing neutralizing antibodies to adenovirus types 4 and 7.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12641211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset: Viral shedding in the stool begins at 7 days; seroconversion occurs ~26 days following vaccination",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: Viral shedding no longer detected at 28 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Passes through stomach to release live virus into the intestine; not detected in serum (limited data; Lyons, 2008)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9524/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lyons A, Longfield J, Kuschner R, et al, &ldquo;A Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of Live, Oral Type 4 and Type 7 Adenovirus Vaccines in Adults,&rdquo;",
"      <i>",
"       Vaccine",
"      </i>",
"      , 2008, 26(23):2890-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9524/abstract-text/18448211/pubmed\" id=\"18448211\" target=\"_blank\">",
"        18448211",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16483 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-125.39.66.147-71980919F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9524=[""].join("\n");
var outline_f9_19_9524=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641206\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641218\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641217\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671326\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671327\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13172357\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641192\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641189\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641219\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641193\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641201\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641197\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641198\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298690\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12757372\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641194\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641195\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641196\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641209\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12641211\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16483\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16483|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/58/20387?source=related_link\">",
"      Adenovirus (types 4, 7) vaccine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_19_9525="Anatomy of thoracic duct";
var content_f9_19_9525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57280&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anatomy of the thoracic duct",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 694px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Course of the thoracic duct from cisterna chyli to left subclavian vein. The right lymphatic duct drains into the right subclavian vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9525=[""].join("\n");
var outline_f9_19_9525=null;
var title_f9_19_9526="Alcoholic steatohepatitis and cirrhosis - low power";
var content_f9_19_9526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alcoholic steatohepatitis and cirrhosis in a 35-year-old woman (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This section of the liver biopsy demonstrated more inflammation and scarring than in the previously shown section.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9526=[""].join("\n");
var outline_f9_19_9526=null;
var title_f9_19_9527="Droperidol: Drug information";
var content_f9_19_9527=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Droperidol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/48/26372?source=see_link\">",
"    see \"Droperidol: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/3/11318?source=see_link\">",
"    see \"Droperidol: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2948709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Droperidol Injection, USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F163613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiemetic;",
"     </li>",
"     <li>",
"      Antipsychotic Agent, Typical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F163578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Titrate carefully to desired effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of PONV:",
"     </b>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer labeling: Maximum initial dose: 2.5 mg; additional doses of 1.25 mg may be administered with caution to achieve desired effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Consensus guideline recommendations: 0.625-1.25 mg I.V. administered at the end of surgery (Gan, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Prevention and treatment of PONV:",
"     </b>",
"     I.V.: 0.625-1.25 mg 30 minutes prior to anticipated end of surgery, and then every 6 hours as needed for breakthrough PONV",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F163598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/3/11318?source=see_link\">",
"      see \"Droperidol: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Titrate carefully to desired effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Prevention of postoperative nausea and vomiting (PONV):",
"     </b>",
"     I.M., I.V.: Children 2-12 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Manufacturer labeling: Maximum dose: 0.1 mg/kg; additional doses may be repeated with caution to achieve desired effect",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Consensus guideline recommendations: 0.01-0.015 mg/kg (maximum: 1.25 mg) I.V. administered at the end of surgery (Gan, 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Canadian labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Prevention and treatment of PONV:",
"     </b>",
"     I.V.: Children &gt;2 years and Adolescents: 0.02-0.05 mg/kg (maximum dose: 1.25 mg) 30 minutes prior to anticipated end of surgery, and then every 6 hours as needed for breakthrough PONV",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F163579\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canadian labeling:",
"     <b>",
"      PONV:",
"     </b>",
"     I.V.: 0.625 mg 30 minutes prior to anticipated end of surgery and then every 6 hours as needed for breakthrough PONV; additional dosing should be administered with caution.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F10578505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling: Specific dosing recommendations are not provided; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling: I.V.: 0.625 mg; additional dosing should be administered with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F10578506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling: Specific dosing recommendations are not provided; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling: I.V.: 0.625 mg; additional dosing should be administered with caution.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F163552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 2.5 mg/mL (2 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 2.5 mg/mL (2 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F163537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F163555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer I.M. or I.V.; according to the manufacturer, I.V. push administration should be slow. For I.V. infusion, further dilute.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F163619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acetaminophen, acyclovir, amifostine, azithromycin, aztreonam, bivalirudin, bleomycin, cisatracurium, cisplatin, cladribine, cyclophosphamide, cytarabine, dexmedetomidine, docetaxel, doxorubicin, doxorubicin liposome, etoposide phosphate, famotidine, fenoldopam, filgrastim, fluconazole, fludarabine, gemcitabine, granisetron, hetastarch in lactated electrolyte injection (Hextend&reg;), hydrocortisone sodium succinate, idarubicin, linezolid, melphalan, meperidine, metoclopramide, mitomycin, ondansetron, oxaliplatin, paclitaxel, potassium chloride, propofol, remifentanil, sargramostim, teniposide, thiotepa, vinblastine, vincristine, vinorelbine, vitamin B complex with C.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol, amphotericin B cholesteryl sulfate complex, cefepime, cefotetan, fluorouracil, foscarnet, furosemide, leucovorin calcium, nafcillin, pemetrexed, piperacillin/tazobactam.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Heparin, methotrexate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Atropine, bleomycin, butorphanol, chlorpromazine, cimetidine, cisplatin, cyclophosphamide, dexamethasone sodium phosphate, dimenhydrinate, diphenhydramine, doxorubicin, fentanyl, glycopyrrolate, hydroxyzine, meperidine, metoclopramide, midazolam, mitomycin, morphine, nalbuphine, pentazocine, prochlorperazine edisylate, promethazine, scopolamine, vinblastine, vincristine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Fluorouracil, furosemide, heparin, leucovorin calcium, methotrexate, pentobarbital.",
"     <b>",
"      Variable (consult detatiled reference):",
"     </b>",
"     Ondansetron.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F163554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and/or treatment of nausea and vomiting from surgical and diagnostic procedures",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F163621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Droperidol may be confused with dronabinol",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F163611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Cardiac arrest, hypertension, hypotension (especially orthostatic), QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation (dose dependent), tachycardia, torsade de pointes, ventricular tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, chills, depression (postoperative, transient), dizziness, drowsiness (postoperative) increased, dysphoria, extrapyramidal symptoms (akathisia, dystonia, oculogyric crisis), hallucinations (postoperative), hyperactivity, neuroleptic malignant syndrome (NMS) (rare), restlessness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, laryngospasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, shivering",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F163558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to droperidol or any component of the formulation; known or suspected QT prolongation, including congenital long QT syndrome (prolonged QT",
"     <sub>",
"      c",
"     </sub>",
"     is defined as &gt;440 msec in males or &gt;450 msec in females)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Not for use in children &le;2 years of age",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F163541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias:",
"     <b>",
"      [U.S. Boxed Warning]: Cases of QT prolongation and torsade de pointes, including some fatal cases, have been reported.",
"     </b>",
"     Use extreme caution in patients with bradycardia (&lt;50 bpm), cardiac disease, concurrent MAO inhibitor therapy, Class I and Class III antiarrhythmics or other drugs known to prolong QT interval, and electrolyte disturbances (hypokalemia or hypomagnesemia), including concomitant drugs which may alter electrolytes (diuretics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, urinary retention, BPH, xerostomia, or visual problems. Relative to other neuroleptics, droperidol has a low potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Has been associated with antipsychotic use; use with caution in patients at risk of pneumonia (eg, Alzheimer&rsquo;s disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms (EPS): May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia. Risk of dystonia (and possibly other EPS) may be greater with increased doses, use of conventional antipsychotics, males, and younger patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): Use may be associated with neuroleptic malignant syndrome (NMS); monitor for mental status changes, fever, muscle rigidity and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension: May cause orthostatic hypotension; use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May be sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with narrow-angle glaucoma; condition may be exacerbated by cholinergic blockade. Screening is recommended. Relative to other neuroleptics, droperidol has a low potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis; condition may be exacerbated by cholinergic blockade. Relative to other neuroleptics, droperidol has a low potency of cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma: Use with caution in patients with pheochromocytoma; severe hypertension and/or tachycardia may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prolactin-dependent tumors: Use with caution in breast cancer or other prolactin-dependent tumors; may elevate prolactin levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures: Use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antiemetic effects: May mask toxicity of other drugs or conditions (eg, intestinal obstruction, Reye's syndrome, brain tumor) due to antiemetic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; reduce initial dose.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F163546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): May diminish the therapeutic effect of Antipsychotics (Typical). Antipsychotics (Typical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist). Management: Avoid concomitant therapy if possible and monitor for decreased effects of both agents when these combinations cannot be avoided. Atypical antipsychotics such as clozapine and quetiapine may be less likely to reduce the effects of anti-Parkinson's agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: Droperidol may enhance the CNS depressant effect of CNS Depressants.  Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: Moderate Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Droperidol may enhance the adverse/toxic effect of Metoclopramide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Droperidol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Moderate Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F163548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F163561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     While teratogenicity has not been demonstrated in animal studies, a slight increase in fetal mortality rate has been observed in some animal studies. Droperidol crosses the placenta. Use during pregnancy only if the potential benefits outweigh potential risks to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F163585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323124\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Droperidol Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2.5 mg/mL (2 mL): $2.42",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F163550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To identify QT prolongation, a 12-lead ECG prior to use is recommended; continued ECG monitoring for 2-3 hours following administration is recommended. Vital signs; serum magnesium and potassium; mental status, abnormal involuntary movement scale (AIMS); observe for dystonias, extrapyramidal side effects, and temperature changes",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Dehidrobenzoperidol (PT);",
"     </li>",
"     <li>",
"      Dehidrobenzperidol (ES);",
"     </li>",
"     <li>",
"      Dehydrobenzperidol (AE, AT, BE, BH, CY, CZ, DE, DK, EG, FI, IL, IQ, IR, JO, KW, LB, LU, LY, NL, OM, QA, SA, SY, TH, TR, YE);",
"     </li>",
"     <li>",
"      Dridol (NO, SE);",
"     </li>",
"     <li>",
"      Droleptan (AU, FR, GB, IE);",
"     </li>",
"     <li>",
"      Dropedol (TW);",
"     </li>",
"     <li>",
"      Dropel (TW);",
"     </li>",
"     <li>",
"      Droperidol (PL);",
"     </li>",
"     <li>",
"      Droperol (IN);",
"     </li>",
"     <li>",
"      Inapsin (ZA);",
"     </li>",
"     <li>",
"      Sintodian (IT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F163540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Droperidol is a butyrophenone antipsychotic; antiemetic effect is a result of blockade of dopamine stimulation of the chemoreceptor trigger zone. Other effects include alpha-adrenergic blockade, peripheral vascular dilation, and reduction of the pressor effect of epinephrine resulting in hypotension and decreased peripheral vascular resistance; may also reduce pulmonary artery pressure",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F163557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: 3-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: ~30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 2-4 hours, may extend to 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Crosses blood-brain barrier and placenta",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : Children: ~0.6 L/kg; Adults: ~1.5 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 85% to 90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic, to",
"     <i>",
"      p",
"     </i>",
"     -fluorophenylacetic acid, benzimidazolone,",
"     <i>",
"      p",
"     </i>",
"     -hydroxypiperidine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~2.3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (75%, &lt;1% as unchanged drug); feces (22%, 11% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cressman WA, Plostnieks J, and Johnson PC, &ldquo;Absorption, Metabolism and Excretion of Droperidol by Human Subjects Following Intramuscular and Intravenous Administration,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1973, 38(4):363-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/4707581/pubmed\" id=\"4707581\" target=\"_blank\">",
"        4707581",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gan TJ, Meyer TA, Apfel CC, et al, &ldquo;Society for Ambulatory Anesthesia Guidelines for the Management of Postoperative Nausea and Vomiting,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2007, 105(6):1615-28.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/18042859/pubmed\" id=\"18042859\" target=\"_blank\">",
"        18042859",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ghoneim MM and Korttila K, &ldquo;Pharmacokinetics of Intravenous Anaesthetics: Implications for Clinical Use,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1977, 2(5):344-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/21053/pubmed\" id=\"21053\" target=\"_blank\">",
"        21053",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grunberg SM and Hesketh PJ, &ldquo;Control of Chemotherapy-Induced Emesis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 329(24):1790-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/8232489/pubmed\" id=\"8232489\" target=\"_blank\">",
"        8232489",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jackson CW, Sheehan AH, and Reddan JG, &ldquo;Evidence-Based Review of the Black-Box Warning for Droperidol&rdquo;,",
"      <i>",
"       AJHP",
"      </i>",
"      , 2007, 64(11):1174-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/17519460/pubmed\" id=\"17519460\" target=\"_blank\">",
"        17519460",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kao LW, Kirk MA, Evers SJ, et al, &ldquo;Droperidol, QT Prolongation, and Sudden Death: What Is the Evidence,&rdquo;",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2003, 41(4):546-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/12658255/pubmed\" id=\"12658255\" target=\"_blank\">",
"        12658255",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Leslie JB and Gan TJ, &ldquo;Meta-Analysis of the Safety of 5-HT3 Antagonists With Dexamethasone or Droperidol for Prevention of PONV,\"",
"      <i>",
"       Ann Pharacother",
"      </i>",
"      , 2006, 40(5):856-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/16670360/pubmed\" id=\"16670360\" target=\"_blank\">",
"        16670360",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McKeage K, Simpson D, and Wagstaff AJ, &ldquo;Intravenous Droperidol: A Review of Its Use in the Management of Postoperative Nausea and Vomiting,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 2006, 66(16):2123-47.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nuttall G, Eckerman K, Jacob K, et al, &ldquo;Does Low-dose Droperidol Administration Increase the Risk of Drug-Induced QT Prolongation and Torsade de Pointes in the General Surgical Population?&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 2007, 107(4):531-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/17893447/pubmed\" id=\"17893447\" target=\"_blank\">",
"        17893447",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Peabody CA, Warner MD, Whiteford HA, et al, &ldquo;Neuroleptics and the Elderly,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1987, 35(3):233-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/2880887/pubmed\" id=\"2880887\" target=\"_blank\">",
"        2880887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rosen C, Ratliff AF, Wolfe RW, et al, &ldquo;The Efficacy of Droperidol in the Prehospital Setting,&rdquo;",
"      <i>",
"       Acad Emerg Med",
"      </i>",
"      , 1995, 2:446.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Saltz BL, Woerner MG, Kane JM, et al, &ldquo;Prospective Study of Tardive Dyskinesia Incidence in the Elderly,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 266(17):2402-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/1681122/pubmed\" id=\"1681122\" target=\"_blank\">",
"        1681122",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seifert RD, &ldquo;Therapeutic Drug Monitoring: Psychotropic Drugs,&rdquo;",
"      <i>",
"       J Pharm Pract",
"      </i>",
"      , 1984, 6:403-16.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sridhar KS and Donnelly E, &ldquo;Combination Antiemetics for Cisplatin Chemotherapy,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 1988, 61(8):1508-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/3280112/pubmed\" id=\"3280112\" target=\"_blank\">",
"        3280112",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tortorice PV and O'Connell MB, &ldquo;Management of Chemotherapy-Induced Nausea and Vomiting,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1990, 10(2):129-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/2190193/pubmed\" id=\"2190193\" target=\"_blank\">",
"        2190193",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilhelm SM, Dehoorne-Smith ML, and Kale-Pradhan PB, &ldquo;Prevention of Postoperative Nausea and Vomiting,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2007, 41(1):68-78.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/17200430/pubmed\" id=\"17200430\" target=\"_blank\">",
"        17200430",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilson J, Weltz M, Solimando D, et al, &ldquo;Continuous Infusion Droperidol: Antiemetic Therapy for Cis-Platinum (DDP) Toxicity,&rdquo;",
"      <i>",
"       Proc Am Soc Clin Oncol",
"      </i>",
"      , 1981, C-351.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yaster M, Sola JE, Pegoli W Jr, et al, &ldquo;The Night After Surgery: Postoperative Management of the Pediatric Outpatient - Surgical and Anesthetic Aspects,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1994, 41(1):199-220.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?9/19/9527/abstract-text/8295803/pubmed\" id=\"8295803\" target=\"_blank\">",
"        8295803",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9395 Version 47.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-3836C529BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9527=[""].join("\n");
var outline_f9_19_9527=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708711\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2948709\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163613\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163578\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163598\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163579\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10578505\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10578506\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163552\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163537\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163555\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163619\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163554\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163621\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163611\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163558\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163541\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299238\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163546\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163548\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163561\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163585\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323124\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163550\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038606\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163540\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163557\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9395\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9395|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?25/48/26372?source=related_link\">",
"      Droperidol: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/3/11318?source=related_link\">",
"      Droperidol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_19_9528="Fusarium diagnostic clues";
var content_f9_19_9528=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Diagnostic clues for invasive fusariosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 722px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9528=[""].join("\n");
var outline_f9_19_9528=null;
var title_f9_19_9529="Non-hormonal performance enhancement";
var content_f9_19_9529=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Non-hormonal performance enhancement",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     David Baron, MSEd, DO, DFAPA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     Alvin M Matsumoto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?9/19/9529/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?9/19/9529/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H16906621\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Performance-enhancing drugs have been used in a variety of settings by both athletes and non-athletes. Individuals are taking performance-enhancing drugs not only to improve athletic performance, but also to increase alertness or improve appearance. Although the focus of news media is on competing athletes who are caught illegally using hormonal agents (eg, androgens, growth hormones) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/1\">",
"     1",
"    </a>",
"    ], there are several non-hormonal drugs and non-pharmacologic methods of performance enhancement that are currently being used. Non-hormonal drugs include stimulants, recreational drugs, nutritional supplements, beta-agonists, beta-antagonists, and several other prescription medications. Non-pharmacologic enhancement methods include blood transfusions, hypoxia induction techniques (eg, high altitude training), and gene doping.",
"   </p>",
"   <p>",
"    For competitive athletes, clinicians should be aware of potentially banned agents, as some of these drugs may be taken for medical purposes (eg, diuretics, 5-alpha-reductase inhibitors).",
"   </p>",
"   <p>",
"    This topic will focus on the physical and adverse effects of non-hormonal performance-enhancing drugs, as well as effects of other methods of performance enhancement. The use of hormonal agents for performance enhancement is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=see_link\">",
"     \"Use of androgens and other hormones to enhance athletic performance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1749891546\">",
"    <span class=\"h1\">",
"     NONHORMONAL PERFORMANCE ENHANCING DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past decade the World Anti-Doping Agency (WADA) list of banned performance-enhancing drugs has grown to over 100 drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition to androgens and other hormones, the WADA prohibited list includes stimulants, recreational drugs such as narcotics and cannabinoids, beta agonists, diuretics, and other prescription medications; the list can be found on the",
"    <a class=\"external\" href=\"file://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/\">",
"     WADA website",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909000\">",
"    <span class=\"h2\">",
"     Stimulants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stimulants include amphetamine, D-methamphetamine, ephedrine, caffeine,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    , dimethylamylamine (DMAA), cocaine, fenfluramine, pemoline,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/54/25448?source=see_link\">",
"     selegiline",
"    </a>",
"    , sibutramine, strychnine, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=see_link\">",
"     modafinil",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3-6\">",
"     3-6",
"    </a>",
"    ]. A survey of college ice hockey players in the United States (US) showed that 52 percent used stimulants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/7\">",
"     7",
"    </a>",
"    ]. Up to 16 percent of college students in the US have used stimulants or prescription cognitive enhancers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. Among German students, stimulants are the most widely used banned substances on the WADA list (13.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/9\">",
"     9",
"    </a>",
"    ]. Stimulants are used by a wide variety of other professions (eg, truck drivers) and in different settings (eg, sexual intercourse, all night parties).",
"   </p>",
"   <p>",
"    Stimulants are banned in sporting events only In-Competition (within 12 hours in which an athlete is scheduled to participate in a sporting event and through the duration of the event itself).",
"   </p>",
"   <p>",
"    Commonly-used stimulants for performance enhancement include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Amphetamine &mdash; Amphetamine was first made in 1887, later used by the military in World War II to increase energy, and is currently used to increase alertness and concentration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/4\">",
"       4",
"      </a>",
"      ]. Although amphetamine, methamphetamine, and cocaine can be drugs of abuse, amphetamine salts (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/44/32454?source=see_link\">",
"       dextroamphetamine",
"      </a>",
"      ) are typically used for treatment, particularly for attention deficit hyperactivity disorder (ADHD). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1784?source=see_link&amp;anchor=H2#H2\">",
"       \"Designer drugs of abuse\", section on 'Amphetamine analogs'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32970?source=see_link\">",
"       \"Cocaine abuse and dependence in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/19/14650?source=see_link&amp;anchor=H5#H5\">",
"       \"Pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents\", section on 'Amphetamines'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/60/39881?source=see_link\">",
"       Methylphenidate",
"      </a>",
"      &mdash; Methylphenidate (also known as Ritalin, Methylin, Concerta, Focalin, and Metadate) is widely used as a cognition enhancer by patients with ADHD. It is also used illegally without a prescription by the general population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/10\">",
"       10",
"      </a>",
"      ]. In US professional baseball, the number of therapeutic exemptions for the use of stimulants to treat ADHD increased almost fourfold in 2007 after stimulants were banned in 2006 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/19/14650?source=see_link&amp;anchor=H2#H2\">",
"       \"Pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents\", section on 'Stimulants'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20599?source=see_link&amp;anchor=H102937184#H102937184\">",
"       \"Pharmacotherapy for adult ADHD\", section on 'Stimulants'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ephedrine &mdash; Over 2.5 million recreational athletes in the US were estimated to have used ephedrine in 2001 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5\">",
"       5",
"      </a>",
"      ]. Ephedrine was marketed as a dietary supplement, but was banned by the US Food and Drug Administration due to risk of heart attack and stroke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3\">",
"       3",
"      </a>",
"      ]. It is still commonly used today for medicinal purposes in Chinese medicine (also known as ma huang, Bolt-Ephedrine, Asia Black 25, Hot Body Ephedra, and Thin Quick). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20554?source=see_link&amp;anchor=H25#H25\">",
"       \"Overview of herbal medicine and dietary supplements\", section on 'Adverse effects'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33866?source=see_link&amp;anchor=H1268592#H1268592\">",
"       \"Drug therapy of obesity\", section on 'Safety'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33866?source=see_link\">",
"       \"Drug therapy of obesity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Caffeine &mdash; Caffeinated products are often used to improve athletic performance, as well as increase alertness in non-sporting events. Moderate amounts of caffeine (approximately 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      body mass) can have performance benefits in a variety of sports (eg, endurance events, racquet sports, swimming, running) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/11\">",
"       11",
"      </a>",
"      ]. Caffeine has urinary thresholds set by the International Olympic Committee (IOC) and National Collegiate Athletic Association (NCAA) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/5/17498?source=see_link&amp;anchor=H30#H30\">",
"       \"Benefits and risks of caffeine and caffeinated beverages\", section on 'Athletic performance enhancement'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/5/17498?source=see_link&amp;anchor=H7#H7\">",
"       \"Benefits and risks of caffeine and caffeinated beverages\", section on 'Alertness'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dimethylamylamine &mdash; DMAA (1,3-dimethylamylamine) is an amphetamine derivative that is widely used in sports supplements sold in the United States [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/6\">",
"       6",
"      </a>",
"      ]. Because of health concerns, in 2011 the US military removed supplements containing DMAA from military exchanges [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/13\">",
"       13",
"      </a>",
"      ], and Health Canada classified DMAA as a drug subject to regulation with no approved products [",
"      <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stimulants are known to be both physical and cognitive performance enhancers. Stimulants decrease appetite, increase energy, improve endurance, increase anaerobic performance, decrease feelings of fatigue, improve reaction time, increase concentration, improve working memory, increase alertness, and can lead to weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3,4,12,15\">",
"     3,4,12,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects include headache, nausea, insomnia, anxiety, tremor, agitation, panic attacks, hypertension, tachycardia, and in some instances myocardial infarction and stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3,4,6,12,16\">",
"     3,4,6,12,16",
"    </a>",
"    ]. Higher doses may lead to aggressive behavior and psychosis. They also predispose users to extra exertion which can lead to heatstroke and rhabdomyolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3\">",
"     3",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/60/39881?source=see_link\">",
"     Methylphenidate",
"    </a>",
"    has been shown to increase core temperature even at rest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3\">",
"     3",
"    </a>",
"    ]. One case-control study found an association between stimulant use and sudden unexplained death in children 7 to 19 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/17\">",
"     17",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1159?source=see_link\">",
"     Modafinil",
"    </a>",
"    may also lead to Stevens-Johnson syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211464909\">",
"    <span class=\"h2\">",
"     Recreational drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to stimulants, other potential recreational drugs used for performance enhancement include narcotics, alcohol, cannabinoids, and nicotine. Narcotics, alcohol, and cannabinoids are banned only In-Competition by WADA. Nicotine is not currently a banned substance. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211464916\">",
"    <span class=\"h3\">",
"     Narcotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opiates have been used for increased pain threshold in athletics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. Adverse effects include dependence, nausea, vomiting, constipation, loss of coordination, decreased concentration, and fatigue. Many opiates are detectable with standard urine drug screens. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/44/3784?source=see_link\">",
"     \"Opioid abuse and dependence: Overview and patient evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211464923\">",
"    <span class=\"h3\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol is occasionally used to reduce anxiety for performance in athletic events and is banned in some sports, such as archery, karate, and motorcycling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5\">",
"     5",
"    </a>",
"    ]. Alcohol can be quantified by blood testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27416?source=see_link\">",
"     \"Pharmacotherapy for social anxiety disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1331708244\">",
"    <span class=\"h3\">",
"     Cannabinoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cannabinoids include marijuana and hashish (a resin). The active ingredient is tetrahydrocannabinol (THC). A study of French university students found increased cannabinoid use for &lsquo;sliding sports,&rsquo; including windsurfing, skiing, snowboarding, surfing, and sailing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/18\">",
"     18",
"    </a>",
"    ]. The physical effects of cannabinoids in sports performance are not well-known, but they can reduce anxiety. Adverse effects of cannabinoids include reduced alertness, impaired short-term memory, and psychomotor retardation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. It can cause dysphoria, increased anxiety, paranoia, and psychosis, particularly during its first use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/19\">",
"     19",
"    </a>",
"    ]. Urine testing can detect cannabinoid metabolites. Based on",
"    <span class=\"nowrap\">",
"     gas-chromatography/mass",
"    </span>",
"    spectrometry measurements, WADA sets the acceptable limits of free and conjugated carboxy-THC at 15",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=see_link\">",
"     \"Cannabis use disorders: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211464930\">",
"    <span class=\"h3\">",
"     Nicotine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine may act like a stimulant by reducing anxiety, elevating mood, enhancing weight loss and satiety, and improving attention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/4,15\">",
"     4,15",
"    </a>",
"    ]. Adverse effects associated with chronic use include an increase in risk of cardiovascular disease, chronic obstructive lung disease, and several types of cancer. Nicotine is not prohibited in most sporting events, obviating the need for testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/23/30073?source=see_link\">",
"     \"Cardiovascular effects of nicotine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=see_link\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=see_link\">",
"     \"Cigarette smoking and other risk factors for lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909035\">",
"    <span class=\"h2\">",
"     Nutritional supplements",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the testing for performance-enhancing drugs has expanded to virtually all levels of competition, athletes have turned to over-the-counter nutritional or dietary supplements, assuming they are legal and safe. This is not always the case. One case series reported healthy patients taking dietary supplements laced with steroids who presented with nausea, anorexia, jaundice, severe pruritis, and kidney failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/20\">",
"     20",
"    </a>",
"    ]. Nutritional supplements in general are not seen as performance-enhancing drugs by the public, and are largely unregulated. Some concerns with these products include their lack of testing, contamination with banned substances, and banned products being used under different names [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. These supplements are a potential source for doping violations. At the 2004 Athens Olympic Games over 47 percent of athletes reported use of nutritional supplements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are innumerable substances labeled as nutritional supplements, including vitamins, minerals, herbs, extracts, amino acids, metabolites, or any combination of these and other substances. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"     \"Vitamin supplementation in disease prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20554?source=see_link\">",
"     \"Overview of herbal medicine and dietary supplements\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909042\">",
"    <span class=\"h3\">",
"     Creatine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Creatine is one example of a nutritional supplement contained in several commercial products (eg, Rejuvinix, Cell Tech Hardcore, Muscle Marketing, Femme Advantage, NOZ) specifically advertised for performance enhancement in sports. Creatine is currently not on the WADA list of banned substances and is the most popular nutritional supplement for performance enhancement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/12\">",
"     12",
"    </a>",
"    ]. In one high school in the US, creatine was used by 9 percent of male and 2 percent of female athletes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/22\">",
"     22",
"    </a>",
"    ]. At a university in the US, 48 percent of male and 4 percent of female athletes reported long-term use of creatine supplements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Creatine increases energy through adenosine triphosphate (ATP) production in skeletal muscle during anaerobic exercise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/12\">",
"     12",
"    </a>",
"    ], and particularly enhances performance in short-duration, high-intensity exercise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/24\">",
"     24",
"    </a>",
"    ]. However, no studies suggest that creatine enhances performance in endurance sports. In a meta-analysis of seven trials of young men (&lt;36 years old), creatine supplements combined with resistance training increased the maximal lifting weight for bench press and squat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/25\">",
"     25",
"    </a>",
"    ]. There was no effect in women or older men, and performance of other types of muscular effort did not improve. Subsequent randomized trials have confirmed that creatine increases maximum power output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Another meta-analysis of 12 trials in patients with muscular dystrophies found a similar increase in muscle strength compared to placebo [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/28\">",
"     28",
"    </a>",
"    ]. There are no studies investigating the long-term benefits and risks of creatine supplementation.",
"   </p>",
"   <p>",
"    Side effects of creatine include weight gain and acute interstitial nephritis, with more rapid progression of chronic renal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16389339\">",
"    <span class=\"h2\">",
"     Energy beverages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The consumption of beverages for athletic events began with sports drinks developed to replace electrolytes and carbohydrates lost during physical activity. Beverages evolved to include a variety of stimulants and other additives such as caffeine, taurine, glucuronolactone, B vitamins, antioxidants, trace minerals, guarana, ginkgo biloba, ginseng,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/16/21766?source=see_link\">",
"     L-carnitine",
"    </a>",
"    , and sucrose, among others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/31\">",
"     31",
"    </a>",
"    ]. The energy beverage industry is expanding rapidly, with hundreds of brands currently available. The recommended daily dose of energy beverages is no more than 500 mL, or one can. However, sports enthusiasts routinely drink much more",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    combine with alcohol consumption, which can be particularly dangerous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/32\">",
"     32",
"    </a>",
"    ]. The effects of energy beverages vary based on the individual beverage components and doses. As an example, caffeine content can vary between 50 and 500 mg per can or bottle (",
"    <a class=\"graphic graphic_table graphicRef79304 \" href=\"mobipreview.htm?30/43/31422\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/33\">",
"     33",
"    </a>",
"    ]. Potential adverse effects of energy beverages may be due to caffeine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other components. These adverse effects include dehydration, elevated blood pressure, arrhythmias, seizures, and mood changes. The consumption of energy drinks, alone and in combination with alcohol or other drugs, is associated with increased emergency department visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/5/17498?source=see_link\">",
"     \"Benefits and risks of caffeine and caffeinated beverages\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211465284\">",
"    <span class=\"h2\">",
"     Beta agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta-2 adrenergic agonist drugs are used for the treatment of asthma. There is debate regarding the performance enhancing effects of beta agonists on non-asthmatic athletes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/35\">",
"     35",
"    </a>",
"    ]. Beta agonists increase airway responsiveness. It is unlikely that they lead to improvement in most athletic events in individuals without asthma; however, there is anecdotal evidence of benefits in swimmers who use these agents prior to a race [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"     36",
"    </a>",
"    ]. All beta agonists are prohibited by the World Anti-Doping Agency (WADA) except",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"     albuterol (salbutamol)",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/52/14151?source=see_link\">",
"     formoterol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/63/34806?source=see_link\">",
"     salmeterol",
"    </a>",
"    by inhalation. High levels of even inhaled beta agonists detected in the urine may constitute a positive test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/37\">",
"     37",
"    </a>",
"    ], and the use of these drugs in athletics requires a therapeutic exemption along with pulmonary function testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5,35\">",
"     5,35",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/61/16344?source=see_link\">",
"     Albuterol",
"    </a>",
"    is the most commonly used beta agonist for athletic performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8618?source=see_link\">",
"     \"Beta agonists in asthma: Acute administration and prophylactic use\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some evidence that beta agonists have direct effects on muscle. Oral beta agonists can increase skeletal muscle, inhibit breakdown of protein, and decrease body fat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"     36",
"    </a>",
"    ]. There may be anabolic effects if high doses of beta agonists are inhaled. As an example, clenbuterol is a long-acting beta agonist that was originally developed as a non-steroidal anabolic agent and can increase lean muscle mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/39\">",
"     39",
"    </a>",
"    ]. There is some concern that clenbuterol-contaminated food could result in positive drug testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects of beta agonists include tachycardia, arrhythmias, hypokalemia, increased plasma glucose, and muscle tremor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Beta agonists can be detected by gas or liquid chromatography mass spectrometry or tandem mass spectrometry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H211465291\">",
"    <span class=\"h2\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta blockers are used routinely in the treatment of heart disease, such as heart failure and coronary artery disease. Beta blockers are banned in sports where there is benefit to having a decreased heart rate and increased steadiness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5,36\">",
"     5,36",
"    </a>",
"    ]. They are prohibited in specific sports such as archery, billiards, boules, gymnastics, and shooting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12905?source=see_link\">",
"     \"Use of beta blockers in heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physical effects of beta blockers on performance include a decrease in heart rate, a reduction of hand tremor, and temporary relief of anxiety [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the lack of evidence of efficacy, some practitioners prescribe beta-blockers for performance in speeches (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/49/8986?source=see_link\">",
"     propranolol",
"    </a>",
"    20 mg taken 20 to 30 minutes prior to the event) and other noncompetitive sporting events (eg, dancing) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adverse effects of beta blockers with short-term use include bradycardia, increased airway resistance, and decreased endurance due to reduced maximum workload [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Beta antagonists can be detected by gas chromatography mass spectrometry. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909056\">",
"    <span class=\"h2\">",
"     Other prescription drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several prescription medications have been used for presumed performance enhancing properties:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H408691231\">",
"    <span class=\"h3\">",
"     Diuretics and other masking agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diuretics are generally used in the treatment of hypertension and include thiazides (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    ), loop diuretics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    )",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/12/38085?source=see_link\">",
"     amiloride",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    . They can be used to quickly decrease body mass in sports where there are weight categories (eg, wrestling, boxing) or to alter normal urinary excretion of performance-enhancing drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. Adverse effects include dizziness, lightheadedness, muscle cramps, rash, gout, hypotension, renal insufficiency, and electrolyte imbalances (eg, hypokalemia, metabolic alkalosis); potassium sparing diuretics (eg, amiloride, spironolactone) can cause hyperkalemia, and spironolactone can also cause gynecomastia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/46/13027?source=see_link\">",
"     \"Thiazides versus loop diuretics in treatment of hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/13/39128?source=see_link&amp;anchor=H5#H5\">",
"     \"Mechanism of action of diuretics\", section on 'Potassium-sparing diuretics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Masking agents are products that conceal the presence of a prohibited substance in urine or other samples. These include diuretics,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/18/37157?source=see_link\">",
"     probenecid",
"    </a>",
"    , epitestosterone, 5-alpha reductase inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39301?source=see_link\">",
"     finasteride",
"    </a>",
"    ), and plasma expanders (eg, intravenous administration of albumin,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/5/21588?source=see_link\">",
"     dextran",
"    </a>",
"    , hydroxyethyl starch, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    ). Diuretics are used to increase urine volume and dilute analytes in urines. Epitestosterone is co-administered with testosterone to normalize urine",
"    <span class=\"nowrap\">",
"     testosterone/epitestosterone",
"    </span>",
"    ratio. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=see_link&amp;anchor=H4#H4\">",
"     \"Use of androgens and other hormones to enhance athletic performance\", section on 'Androgens'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Diuretics are best detected by gas or liquid chromatography mass spectrometry or tandem mass spectrometry methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1331708348\">",
"    <span class=\"h3\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids alter glucose metabolism and have anti-inflammatory and analgesic properties, leading some athletes to use them in sporting events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. Glucocorticoids are prohibited only while In-Competition (within 12 hours in which an athlete is scheduled to participate in a sporting event and through the duration of the event itself). Their use and efficacy are not well-documented for performance enhancement. Glucocorticoids may cause hyperglycemia, fluid retention, and acute mood changes. In chronic use they can suppress the hypothalamic-pituitary-adrenal axis and lead to reduced muscle mass and weakness, osteoporosis, diabetes, hypertension, weight gain and abdominal obesity, cataracts, and various psychiatric symptoms (eg, hypomania, depression, psychosis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23208?source=see_link\">",
"     \"Pharmacologic use of glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909070\">",
"    <span class=\"h3\">",
"     Phosphodiesterase 5 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phosphodiesterase 5 inhibitors are generally used to enhance erectile performance based on their vasodilatory effects via nitric oxide. Athletes also use phosphodiesterase 5 inhibitors for presumed effects of increased oxygenation and exercise capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/42\">",
"     42",
"    </a>",
"    ]. However, there are little data available that have evaluated the effect of phosphodiesterase 5 inhibitors on athletic performance. They are not on the WADA prohibited list. Adverse effects include headache, flushing, dyspepsia, hypotension, and blurring of vision. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30282?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of male sexual dysfunction\", section on 'Pharmacotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909077\">",
"    <span class=\"h3\">",
"     Angiotensin converting enzyme inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiotensin-converting enzyme (ACE) inhibitors are routinely used in the treatment of hypertension, coronary artery disease, and heart failure. Individuals with the &lsquo;insertion&rsquo; allele of the ACE gene were found to have a higher maximum oxygen uptake and greater physical performance compared to those with the &lsquo;deletion&rsquo; allele [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/43\">",
"     43",
"    </a>",
"    ]. The insertion allele was found to decrease the activity similar to ACE-inhibitors and may produce lower levels of angiotensin II similar to angiotensin II receptor blockers (ARBs). There are few experimental data to show that ACE-inhibitors and ARBs enhance athletic performance. They are not on the WADA prohibited list. Adverse effects of ACE-inhibitors and ARBs include cough, hypotension, hyperkalemia, renal insufficiency, and angioedema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/40/25224?source=see_link\">",
"     \"Renin-angiotensin system inhibition in the treatment of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909098\">",
"    <span class=\"h3\">",
"     Psychiatric medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antidepressants, anxiolytics, antipsychotics, and anticonvulsants can improve mood and anxiety in general [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/44\">",
"     44",
"    </a>",
"    ]. Antidepressants, anxiolytics, and antipsychotics are prohibited in archery competition by the International Archery Federation. Anticonvulsants may pose ethical dilemmas given similar effects on mood and anxiety but are not currently on the prohibited list. Individual effects, including adverse effects of individual psychiatric medications, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2665?source=see_link\">",
"     \"Pharmacotherapy for generalized anxiety disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43994?source=see_link\">",
"     \"Pharmacology of antiepileptic drugs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=see_link\">",
"     \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H305125\">",
"    <span class=\"h2\">",
"     Detection of use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although testing protocols may vary at any individual site, the standard method of testing for performance enhancement in athletics is a split sample urine test and high performance liquid chromatography analysis. A split sample involves dividing the initial urine collection into two separate containers, labelled \"A\" and \"B\" samples. The samples are then sent to the certified testing lab, following strict chain of custody protocol. The \"A\" sample is run first, and, if positive for a banned drug, the athlete is notified of the positive test and informed that the \"B\" sample will be run to confirm the result. The athlete and a representative are permitted to be present at the running of the \"B\" sample. If a positive test is confirmed by the &ldquo;B&rdquo; sample, the results are turned over to a doping medical review officer for appropriate follow-up. If the initial \"A\" test is negative, the \"B\" sample is not tested.",
"   </p>",
"   <p>",
"    <br/>",
"    The length of time a banned substance will remain in the body depends on a number of clinical variables, including the half-life of the drug, other medications being taken (diuretics and masking agents are banned due to their effects on other drugs, despite not being performance enhancing), and individual",
"    <span class=\"nowrap\">",
"     pharmacodynamic/kinetic",
"    </span>",
"    factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909105\">",
"    <span class=\"h1\">",
"     NON-PHARMACOLOGIC PERFORMANCE ENHANCEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several methods of performance enhancement that do not involve taking drugs. Blood transfusions are among the most common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909112\">",
"    <span class=\"h2\">",
"     Blood transfusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood transfusions can be autologous or homologous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/45\">",
"     45",
"    </a>",
"    ]. Blood transfusions can increase the number of erythrocytes and oxygen carrying capacity in the blood. Blood transfusions prior to athletic competitions have been used to enhance performance, but are currently prohibited by the World Anti-Doping Agency (WADA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5,45\">",
"     5,45",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    Platelet-rich plasma and other platelet-derived preparations contain growth factors but they are not prohibited by WADA.",
"   </p>",
"   <p>",
"    Blood transfusions can lead to sudden changes in blood pressure, promote atherosclerosis, cause oxidative damage to organs, impair blood cell functions, lead to blood-borne infections, and lead to iron deposition in organs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Autologous blood transfusions are not able to be detected. Homologous transfusions can be detected through surface antigen patterns using flow cytometry. As the life of a red blood cell is three to four months, detection can be performed for several weeks after a transfusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909119\">",
"    <span class=\"h2\">",
"     Hypoxia induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The induction of hypoxia leads to a natural response of endogenous erythropoietin production, hemoglobin elevation, and oxygen-carrying capacity. High altitude training and sleeping in negative pressure tents create a hypoxia effect to subsequently improve oxygen-carrying capacity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/41,46\">",
"     41,46",
"    </a>",
"    ]. Although there is physiologic benefit to training at high elevation, the ability to train vigorously is reduced due to low oxygen tension at high altitude. A high-low method of sleeping at high altitude and training at low altitude appears to be better at improving endurance performance than either method alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/47\">",
"     47",
"    </a>",
"    ]. Adverse effects include pulmonary and cerebral edema associated with high altitude illness. High altitude illness can be prevented with slow acclimatization. High altitude training is not currently prohibited by antidoping agencies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/297?source=see_link\">",
"     \"High altitude illness: Physiology, risk factors, and general prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16909126\">",
"    <span class=\"h2\">",
"     Gene doping",
"    </span>",
"    &nbsp;&mdash;&nbsp;&ldquo;Gene doping&rdquo; is the application of gene therapy techniques to enhance athletic performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/48\">",
"     48",
"    </a>",
"    ]. The history of doping in sports clearly demonstrates some athletes will do anything, and risk everything, to gain a competitive advantage.",
"   </p>",
"   <p>",
"    Candidate genes have been identified that effect erythropoietin production, the development of type I and type II muscle fibers, insulin-like growth factor I, and myostatin (a negative regulator of muscle growth), and gene doping has been demonstrated to impact endurance, strength, and tissue repair in animal models [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. As an example, gene therapy has been used to promote erythropoietin production to treat anemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/51\">",
"     51",
"    </a>",
"    ], which makes it a potential target for abuse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To date, there is no evidence of gene doping by athletes, however, the World Anti-Doping Agency (WADA) was concerned enough to include gene doping in its 2003 official list of banned methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/48,49,53\">",
"     48,49,53",
"    </a>",
"    ]. The significant potential for performance enhancement and extension of an athlete&rsquo;s career through improved healing capacity, along with the inherent difficulty in detection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?9/19/9529/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], enhance the risk for this form of abuse. As is the case with virtually all forms of doping, the serious risk to the athlete and the unfair advantage gained by cheaters require close monitoring and an aggressive education campaign by all those involved in doping control policy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16910913\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For competitive athletes, clinicians should be aware of doping regulations, as some banned drugs may be taken for medical purposes (eg, diuretics, 5-alpha-reductase inhibitors). In addition to androgens and other hormones, the World Anti-Doping Agency (WADA) prohibited list includes stimulants, recreational drugs such as narcotics and cannabinoids, beta-agonists, diuretics, and other prescription medications; the list can be found on the",
"      <a class=\"external\" href=\"file://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/\">",
"       WADA website",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H1749891546\">",
"       'Nonhormonal performance enhancing drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although androgens and growth hormone are among the most commonly used performance-enhancing substances, several other drugs may be used for performance enhancement including stimulants, recreational drugs, nutritional supplements, beta agonists, beta&ndash;antagonists, and several other prescription medications. (See",
"      <a class=\"local\" href=\"#H1749891546\">",
"       'Nonhormonal performance enhancing drugs'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=see_link\">",
"       \"Use of androgens and other hormones to enhance athletic performance\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Non-pharmacologic performance enhancement includes blood transfusion, hypoxia induction techniques, and gene doping. (See",
"      <a class=\"local\" href=\"#H16909105\">",
"       'Non-pharmacologic performance enhancement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical and adverse effects vary based on individual pharmacologic and non-pharmacologic methods of enhancement. (See",
"      <a class=\"local\" href=\"#H1749891546\">",
"       'Nonhormonal performance enhancing drugs'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16909105\">",
"       'Non-pharmacologic performance enhancement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/1\">",
"      Catlin DH, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA 1996; 276:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/2\">",
"      Botr&egrave; F, Pavan A. Enhancement drugs and the athlete. Neurol Clin 2008; 26:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/3\">",
"      Eichner ER. Stimulants in sports. Curr Sports Med Rep 2008; 7:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/4\">",
"      Bailey JA, Averbuch RN, Gold MS. Cosmetic Psychiatry. Directions in Psychiatry 2009; 29:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/5\">",
"      Sj&ouml;qvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet 2008; 371:1872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/6\">",
"      Cohen PA. DMAA as a dietary supplement ingredient. Arch Intern Med 2012; 172:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/7\">",
"      Bents RT, Marsh E. Patterns of ephedra and other stimulant use in collegiate hockey athletes. Int J Sport Nutr Exerc Metab 2006; 16:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/8\">",
"      Arria AM, DuPont RL. Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do. J Addict Dis 2010; 29:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/9\">",
"      Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med 2007; 28:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/10\">",
"      Lardon MT. Performance-Enhancing Drugs: Where Should the Line be Drawn and by Whom? Psychiatry (Edgmont) 2008; 5:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/11\">",
"      Burke LM. Caffeine and sports performance. Appl Physiol Nutr Metab 2008; 33:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/12\">",
"      Fernandez MM, Hosey RG. Performance-enhancing drugs snare nonathletes, too. J Fam Pract 2009; 58:16.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.troopsupport.dla.mil/subs/fso/alfood/2011/alf03611.pdf (Accessed on May 22, 2012).",
"    </li>",
"    <li>",
"     file://www.scribd.com/doc/82744576/DMAA-Health-Canada-2011 (Accessed on May 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/15\">",
"      Lanni C, Lenzken SC, Pascale A, et al. Cognition enhancers between treating and doping the mind. Pharmacol Res 2008; 57:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/16\">",
"      Gee P, Tallon C, Long N, et al. Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage. Ann Emerg Med 2012; 60:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/17\">",
"      Gould MS, Walsh BT, Munfakh JL, et al. Sudden death and use of stimulant medications in youths. Am J Psychiatry 2009; 166:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/18\">",
"      Lorente FO, Peretti-Watel P, Grelot L. Cannabis use to enhance sportive and non-sportive performances among French sport students. Addict Behav 2005; 30:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/19\">",
"      Saugy M, Avois L, Saudan C, et al. Cannabis and sport. Br J Sports Med 2006; 40 Suppl 1:i13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/20\">",
"      Krishnan PV, Feng ZZ, Gordon SC. Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J Clin Gastroenterol 2009; 43:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/21\">",
"      Tsitsimpikou C, Tsiokanos A, Tsarouhas K, et al. Medication use by athletes at the Athens 2004 Summer Olympic Games. Clin J Sport Med 2009; 19:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/22\">",
"      Metzl JD, Small E, Levine SR, Gershel JC. Creatine use among young athletes. Pediatrics 2001; 108:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/23\">",
"      LaBotz M, Smith BW. Creatine supplement use in an NCAA Division I athletic program. Clin J Sport Med 1999; 9:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/24\">",
"      Graham AS, Hatton RC. Creatine: a review of efficacy and safety. J Am Pharm Assoc (Wash) 1999; 39:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/25\">",
"      Dempsey RL, Mazzone MF, Meurer LN. Does oral creatine supplementation improve strength? A meta-analysis. J Fam Pract 2002; 51:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/26\">",
"      Kendall KL, Smith AE, Graef JL, et al. Effects of four weeks of high-intensity interval training and creatine supplementation on critical power and anaerobic working capacity in college-aged men. J Strength Cond Res 2009; 23:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/27\">",
"      Okudan N, Gokbel H. The effects of creatine supplementation on performance during the repeated bouts of supramaximal exercise. J Sports Med Phys Fitness 2005; 45:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/28\">",
"      Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev 2011; :CD004760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/29\">",
"      Koshy KM, Griswold E, Schneeberger EE. Interstitial nephritis in a patient taking creatine. N Engl J Med 1999; 340:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/30\">",
"      Edmunds JW, Jayapalan S, DiMarco NM, et al. Creatine supplementation increases renal disease progression in Han:SPRD-cy rats. Am J Kidney Dis 2001; 37:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/31\">",
"      Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc 2010; 85:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/32\">",
"      Ballard SL, Wellborn-Kim JJ, Clauson KA. Effects of commercial energy drink consumption on athletic performance and body composition. Phys Sportsmed 2010; 38:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/33\">",
"      Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks--a growing problem. Drug Alcohol Depend 2009; 99:1.",
"     </a>",
"    </li>",
"    <li>",
"     Subastance Abuse and Mental Health Services Administration. The DAWN Report: Emergency Department Visits Involving Energy Drinks. Report, Center for Behavioral Health Statistics and Quality; Rockville, MD 2011.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/35\">",
"      Alaranta A, Alaranta H, Helenius I. Use of prescription drugs in athletes. Sports Med 2008; 38:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/36\">",
"      Davis E, Loiacono R, Summers RJ. The rush to adrenaline: drugs in sport acting on the beta-adrenergic system. Br J Pharmacol 2008; 154:584.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf (Accessed on June 07, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/38\">",
"      Lippi G, Franchini M, Favaloro EJ, Guidi GC. Salbutamol in athletes. Clin J Sport Med 2008; 18:469; author reply 469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/39\">",
"      Kamalakkannan G, Petrilli CM, George I, et al. Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. J Heart Lung Transplant 2008; 27:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/40\">",
"      Guddat S, Fu&szlig;h&ouml;ller G, Geyer H, et al. Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. Drug Test Anal 2012; 4:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/41\">",
"      Spedding M, Spedding C. Drugs in sport: a scientist-athlete's perspective: from ambition to neurochemistry. Br J Pharmacol 2008; 154:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/42\">",
"      Petr&oacute;czi A, Naughton DP. Potentially fatal new trend in performance enhancement: a cautionary note on nitrite. J Int Soc Sports Nutr 2010; 7:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/43\">",
"      Wang P, Fedoruk MN, Rupert JL. Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents? Sports Med 2008; 38:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/44\">",
"      Kaufman KR. Anticonvulsants in sports: ethical considerations. Epilepsy Behav 2007; 10:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/45\">",
"      Thevis M, Kohler M, Sch&auml;nzer W. New drugs and methods of doping and manipulation. Drug Discov Today 2008; 13:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/46\">",
"      Elliott S. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol 2008; 154:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/47\">",
"      Schmitt L, Millet G, Robach P, et al. Influence of \"living high-training low\" on aerobic performance and economy of work in elite athletes. Eur J Appl Physiol 2006; 97:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/48\">",
"      McKanna TA, Toriello HV. Gene doping: the hype and the harm. Pediatr Clin North Am 2010; 57:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/49\">",
"      Battery L, Solomon A, Gould D. Gene doping: Olympic genes for Olympic dreams. J R Soc Med 2011; 104:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/50\">",
"      Wells DJ. Gene doping: possibilities and practicalities. Med Sport Sci 2009; 54:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/51\">",
"      Binley K, Askham Z, Iqball S, et al. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 2002; 100:2406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/52\">",
"      Diamanti-Kandarakis E, Konstantinopoulos PA, Papailiou J, et al. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era. Sports Med 2005; 35:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/53\">",
"      Rivera VM, Gao GP, Grant RL, et al. Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 2005; 105:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/54\">",
"      Lasne F, Thioulouse J, Martin L, de Ceaurriz J. Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis. Electrophoresis 2007; 28:1875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?9/19/9529/abstract/55\">",
"      Beiter T, Zimmermann M, Fragasso A, et al. Direct and long-term detection of gene doping in conventional blood samples. Gene Ther 2011; 18:225.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15454 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-31C67D9254-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9529=[""].join("\n");
var outline_f9_19_9529=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16910913\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16906621\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1749891546\">",
"      NONHORMONAL PERFORMANCE ENHANCING DRUGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909000\">",
"      Stimulants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H211464909\">",
"      Recreational drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H211464916\">",
"      - Narcotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H211464923\">",
"      - Alcohol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1331708244\">",
"      - Cannabinoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H211464930\">",
"      - Nicotine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909035\">",
"      Nutritional supplements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16909042\">",
"      - Creatine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16389339\">",
"      Energy beverages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H211465284\">",
"      Beta agonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H211465291\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909056\">",
"      Other prescription drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H408691231\">",
"      - Diuretics and other masking agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1331708348\">",
"      - Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16909070\">",
"      - Phosphodiesterase 5 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16909077\">",
"      - Angiotensin converting enzyme inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16909098\">",
"      - Psychiatric medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H305125\">",
"      Detection of use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16909105\">",
"      NON-PHARMACOLOGIC PERFORMANCE ENHANCEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909112\">",
"      Blood transfusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909119\">",
"      Hypoxia induction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16909126\">",
"      Gene doping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16910913\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/15454\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/15454|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/43/31422\" title=\"table 1\">",
"      Caffeine content",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/5/17498?source=related_link\">",
"      Benefits and risks of caffeine and caffeinated beverages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/26/8618?source=related_link\">",
"      Beta agonists in asthma: Acute administration and prophylactic use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=related_link\">",
"      Cannabis use disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/23/30073?source=related_link\">",
"      Cardiovascular effects of nicotine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/12/32970?source=related_link\">",
"      Cocaine abuse and dependence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/47/1784?source=related_link\">",
"      Designer drugs of abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/4/33866?source=related_link\">",
"      Drug therapy of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=related_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/297?source=related_link\">",
"      High altitude illness: Physiology, risk factors, and general prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/13/39128?source=related_link\">",
"      Mechanism of action of diuretics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/44/3784?source=related_link\">",
"      Opioid abuse and dependence: Overview and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/4/20554?source=related_link\">",
"      Overview of herbal medicine and dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/42/23208?source=related_link\">",
"      Pharmacologic use of glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/19/14650?source=related_link\">",
"      Pharmacology of drugs used to treat attention deficit hyperactivity disorder in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/7/20599?source=related_link\">",
"      Pharmacotherapy for adult ADHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/38/2665?source=related_link\">",
"      Pharmacotherapy for generalized anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/49/27416?source=related_link\">",
"      Pharmacotherapy for social anxiety disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/40/25224?source=related_link\">",
"      Renin-angiotensin system inhibition in the treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/46/13027?source=related_link\">",
"      Thiazides versus loop diuretics in treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30282?source=related_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/35/21050?source=related_link\">",
"      Use of androgens and other hormones to enhance athletic performance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12905?source=related_link\">",
"      Use of beta blockers in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=related_link\">",
"      Vitamin supplementation in disease prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_19_9530="Mild FGS Light";
var content_f9_19_9530=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F67677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F67677&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mild FGS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph shows early changes in focal glomerulosclerosis with segmental capillary collapse (arrows) in areas of epithelial cell injury (small arrowhead).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9530=[""].join("\n");
var outline_f9_19_9530=null;
var title_f9_19_9531="Rapid rx myasthenia";
var content_f9_19_9531=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid therapies for myasthenia gravis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Plasmapheresis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Intravenous immune globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Usual adult dose",
"       </td>",
"       <td>",
"        Five exchange treatments of 3 to 5 liters over 10 to 14 days",
"       </td>",
"       <td>",
"        400 mg/kg daily for five days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Onset of effect",
"       </td>",
"       <td>",
"        1 to 7 days",
"       </td>",
"       <td>",
"        1 to 2 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximal effect",
"       </td>",
"       <td>",
"        1 to 3 weeks",
"       </td>",
"       <td>",
"        1 to 3 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adverse effects",
"       </td>",
"       <td>",
"        Line infection, hypotension, thromboembolism",
"       </td>",
"       <td>",
"        Headache, fluid overload, renal failure (rare)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9531=[""].join("\n");
var outline_f9_19_9531=null;
var title_f9_19_9532="Etiologies of expressive delay";
var content_f9_19_9532=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50911&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected causes of and contributing factors to expressive language delay in young children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Cause/Contributing factor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maturational language delay* (constitutional language delay)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hearing impairment",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prematurity and/or low birth weight",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious diseases",
"       </td>",
"       <td>",
"        Intrauterine infection, meningitis, HIV/AIDS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurologic conditions",
"       </td>",
"       <td>",
"        Seizures, cerebral palsy, apraxia of speech, etc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic conditions",
"       </td>",
"       <td>",
"        Hypothyroidism, phenylketonuria, etc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxicologic conditions",
"       </td>",
"       <td>",
"        Lead poisoning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Genetic conditions",
"       </td>",
"       <td>",
"        Down syndrome, fragile X syndrome, Williams syndrome, neurofibromatosis, tuberous sclerosis, etc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history",
"       </td>",
"       <td>",
"        Language delay, learning problems, dyslexia, cognitive disability, etc.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Socioeconomic factors",
"       </td>",
"       <td>",
"        Poverty, low parental educational attainment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of language stimulation, parent-child dysfunction, or disruption in parenting",
"       </td>",
"       <td>",
"        Maternal depression, child neglect or abuse, time spent in an orphanage, multiple foster care placements, etc.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Maturational language delay is a diagnosis made in younger children who are in the early developmental period. These delays may resolve in some children or progress to a more specific diagnosis by the age of school entry. However, making the functional diagnosis of maturational language delay may allow the child to receive treatment services while the other causes of language delay are being evaluated.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9532=[""].join("\n");
var outline_f9_19_9532=null;
var title_f9_19_9533="Surveillance case definition HIV adults and adolescents";
var content_f9_19_9533=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65478&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Surveillance case definition for human immunodeficiency virus (HIV) infection among adults and adolescents (&ge;13 years) - United States, 2008",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Laboratory evidence*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Stage 1",
"       </td>",
"       <td>",
"        Laboratory confirmation of HIV infection",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td rowspan=\"3\">",
"        None required (but no AIDS-defining condition)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte count of &ge;500 cells/&micro;L",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte percentage of &ge;29",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Stage 2",
"       </td>",
"       <td>",
"        Laboratory confirmation of HIV infection",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td rowspan=\"3\">",
"        None required (but no AIDS-defining condition)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte count of 200-499 cells/&micro;L",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte percentage of 14-28",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Stage 3 (AIDS)",
"       </td>",
"       <td>",
"        Laboratory confirmation of HIV infection",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td rowspan=\"3\">",
"        <strong>",
"         or",
"        </strong>",
"        documentation of an AIDS-defining condition (with laboratory confirmation of HIV infection)&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte count of &lt;200 cells/&micro;L",
"        <strong>",
"         or",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CD4+ T-lymphocyte percentage of &lt;14&bull;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Stage unknown&Delta;",
"       </td>",
"       <td>",
"        Laboratory confirmation of HIV infection",
"        <strong>",
"         and",
"        </strong>",
"       </td>",
"       <td rowspan=\"2\">",
"        <strong>",
"         and",
"        </strong>",
"        no information on presence of AIDS-defining conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        no information on CD4+ T-lymphocyte count or percentage",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The CD4+ T-lymphocyte percentage is the percentage of total lymphocytes. If the CD4+ T-lymphocyte count and percentage do not correspond to the same HIV infection stage, select the more severe stage.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Documentation of an AIDS-defining condition supersedes a CD4+ T-lymphocyte count of &le;200 cells/&micro;L and a CD4+ T-lymphocyte percentage of total lymphocytes of &ge;14. Definitive diagnostic methods for these conditions are available in Appendix C of the 1993 revised HIV classification system and the expanded AIDS case definition (CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41[No. RR-17]) and from the National Notifiable Diseases Surveillance System (available at",
"      <a href=\"file://www.cdc.gov/epo/dphsi/casedef/case_definitions.htm\">",
"       file://www.cdc.gov/epo/dphsi/casedef/case_definitions.htm",
"      </a>",
"      ).",
"      <br>",
"       &Delta; Although cases with no information on CD4+ T-lymphocyte count or percentage or on the presence of AIDS-defining conditions can be classified as stage unknown, every effort should be made to report CD4+ T-lymphocyte counts or percentages and the presence of AIDS-defining conditions at the time of diagnosis. Additional CD4+ T-lymphocyte counts or percentages and any identified AIDS-defining conditions can be reported as recommended. (Council of State and Territorial Epidemiologists. Laboratory reporting of clinical test results indicative of HIV infection: new standards for a new era of surveillance and prevention [Position Statement 04-ID-07]; 2004. Available at",
"       <a href=\"file://www.cste.org/ps/2004pdf/04-ID-07-final.pdf\" target=\"_blank\">",
"        file://www.cste.org/ps/2004pdf/04-ID-07-final.pdf",
"       </a>",
"       .)",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Centers for Disease Control and Prevention. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged &lt;18 months and for HIV infection and AIDS among children aged 18 months to &lt;13 years - United States, 2008. MMWR 2008; 57 (RR-10):4.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9533=[""].join("\n");
var outline_f9_19_9533=null;
var title_f9_19_9534="Contents: Surgery";
var content_f9_19_9534=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?18/22/18798\">",
"       Patient Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Surgery",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Surgery",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Breast reconstruction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/62/11236\">",
"           Patient information: Breast reconstruction after mastectomy (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Colectomy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/9/38034\">",
"           Patient information: Colectomy (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11875\">",
"           Patient information: Colostomy care (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gallbladder removal (cholecystectomy)",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/56/1923\">",
"           Patient information: Gallbladder removal (cholecystectomy) (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         General surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/42/6818\">",
"           Patient information: Anesthesia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/48/19202\">",
"           Patient information: Endovascular surgery (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/22/25954\">",
"           Patient information: Minimally invasive surgery (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/52/30530\">",
"           Patient information: Questions to ask if you are having a procedure or surgery (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gynecologic surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/16/6405\">",
"           Patient information: Abdominal hysterectomy (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/27/28083\">",
"           Patient information: Care after gynecologic surgery (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/24/8578\">",
"           Patient information: Dilation and curettage (D and C) (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/8/143\">",
"           Patient information: Endometrial ablation (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/28/7620\">",
"           Patient information: Permanent sterilization procedures for women (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/21/2386\">",
"           Patient information: Uterine artery embolization (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/48/34564\">",
"           Patient information: Vaginal hysterectomy (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hernia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/53/14162\">",
"           Patient information: Abdominal wall hernias (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/33/37393\">",
"           Patient information: Hiatal hernia (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/62/42977\">",
"           Patient information: Inguinal and femoral (groin) hernias (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Preparing for surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/52/30530\">",
"           Patient information: Questions to ask if you are having a procedure or surgery (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Weight loss surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/37/9811\">",
"           Patient information: Weight loss surgery (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/31/14835\">",
"           Patient information: Weight loss surgery (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-853974C8A1-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f9_19_9534=[""].join("\n");
var outline_f9_19_9534=null;
var title_f9_19_9535="Models basal ganglia dysfunction";
var content_f9_19_9535=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F82136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F82136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Models of basal ganglia dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 378px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This schematic drawing of the basal ganglia and their connections illustrates the main striato-fugal pathways. In PD, the inhibitory direct pathway mediated via D2 striatal receptors has been postulated to be overactive whereas the inhibitory direct mediated via D1 striatal receptors has been underactive as a result of which the main outflow pallidal-thalamic pathway provides inhibitory input to the thalamus and results in suppression of thalamo-cortical-spinal pathway manifested clinically by paucity and slowness of movement (bradykinesia). In contrast, the abnormal function in the basal ganglia of hyperkinetic movement disorders presumably leads to disinhibition of the thalamo-cortical-striatal pathway manifested clinically by excessive abnormal involuntary movements such as chorea, hemiballism (HB), tics as seen in Tourette syndrome (TS), and dystonia.",
"    <div class=\"footnotes\">",
"     Green: excitatory; Red: inhibitory; GPe: globus pallidus externa; GPi: globus pallidus interna; SNc: substantia nigra pars compacta; SNr: substantia nigra pars reticulata; TH: ventrolateral nucleus of the thalamus.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_19_9535=[""].join("\n");
var outline_f9_19_9535=null;
